Evidence map›Paper›PMID 37656796›Full record

ArticleScience advances2023

The cellular response to extracellular vesicles is dependent on their cell source and dose.

Daniel W Hagey, Miina Ojansivu, Beklem R Bostancioglu, Osama Saher, Jeremy P Bost, Manuela O Gustafsson, Roberto Gramignoli, Mathias Svahn, Dhanu Gupta, Molly M Stevens and 2 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Defining extracellular vesicle dose in nanoliter embryo culture.Journal of assisted reproduction and genetics · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Extracellular vesicle-mediated crosstalk in bone: miR-150-5p as a mechanosensitive regulator of osteoclastogenesis.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Rethinking Extracellular Vesicle Signaling.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Does extracellular vesicle specificity truly exist?Cell communication and signaling : CCS · 2026
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 4 countries.

Daniel W HageyDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0001-9246-6235
Miina OjansivuDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-5493-3530
Beklem R BostanciogluDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0001-6755-6968
Osama SaherDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0003-3286-5706
Jeremy P BostDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-3804-0521
Manuela O GustafssonDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Roberto GramignoliDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0003-3362-4170
Mathias SvahnNextCell Pharma AB, Stockholm, Sweden.ORCID 0000-0002-9485-9320
Dhanu GuptaDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Molly M StevensDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-7335-266X
André GörgensDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0001-9198-0857
Samir El AndaloussiDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Karolinska University Hospital · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) have been established to play important roles in cell-cell communication and shown promise as therapeutic agents. However, we still lack a basic understanding of how cells respond upon exposure to EVs from different cell sources at various doses. Thus, we treated fibroblasts with EVs from 12 different cell sources at doses between 20 and 200,000 per cell, analyzed their transcriptional effects, and functionally confirmed the findings in various cell types in vitro, and in vivo using single-cell RNA sequencing. Unbiased global analysis revealed EV dose to have a more significant effect than cell source, such that high doses down-regulated exocytosis and up-regulated lysosomal activity. However, EV cell source-specific responses were observed at low doses, and these reflected the activities of the EV's source cells. Last, we assessed EV-derived transcript abundance and found that immune cell-derived EVs were most associated with recipient cells. Together, this study provides important insights into the cellular response to EVs.

Indexed as

Extracellular VesiclesCell CommunicationExocytosisFibroblasts

Identifiers

PMID37656796
PMCPMC11629882
OpenAlexW4386356552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.